Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90293973

Filing Date: 11/02/2020

To the Commissioner for Trademarks:

MARK: eCLIP (Standard Characters, see mark)
The literal element of the mark consists of eCLIP. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Eclipse Bioinnovations, Inc., a corporation of Delaware, having an address of
      6195 Cornerstone Court East #105
      San Diego, California 92121
      United States
      858-255-8115(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  eCLIP services use the enhanced crosslinking and immunoprecipitation technology to identify RNA binding proteins. Services are all inclusive, from lysis through library preparation, sequencing and primary data processing for biotech, pharma, and academic customers.

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/01/2017, and first used in commerce at least as early as 06/01/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, .
Specimen File1

International Class 001:  001-934 Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes. Enhanced crosslinking and immunoprecipitation followed by high-throughput sequencing (eCLIP) is a simplified and robust RNA library preparation kit to identify RNA-binding proteins targets for biotech, pharma, and academic customers.

In International Class 001, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/01/2017, and first used in commerce at least as early as 06/01/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, .
Specimen File1

The applicant's current Correspondence Information:

Eclipse Bioinnovations, Inc.

PRIMARY EMAIL FOR CORRESPONDENCE: jason.santos@eclipsebio.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): notifications@trademarkengine.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Peter Chu/   Date: 10/28/2020
Signatory's Name: Peter Chu
Signatory's Position: CEO
Payment Sale Number: 90293973
Payment Accounting Date: 11/02/2020

Serial Number: 90293973
Internet Transmission Date: Mon Nov 02 17:29:07 ET 2020
TEAS Stamp: USPTO/BAS-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20201102172907571973-90293973-
7505bc1e3b9c8ad4bd6fbdab9bb1d0f33d5c471f
bb5a7dd539992c4b8869f8652-CC-29068030-20
201028131100011492